Up to 10% of women of childbearing age are affected by endometriosis, a disease with debilitating symptoms that is often diagnosed late. Despite its high prevalence among symptomatic patients, the journey to diagnosis remains long and complex due to the lack of a reliable biological marker. A glimmer of hope: the ENDOBEST study, launched in May 2025, is evaluating a non-invasive saliva test that could finally simplify and speed up treatment. This is an innovation to watch clo

Francesca Scurtu shares her unique experience of research and clinical training at IFEM Endo Bordeaux, under the supervision of Professor Horace Roman, a world-renowned expert in the field of endometriosis.